1. Role Of Bevacizumab As A Prophylactic And Rehabilitative Treatment Modality In Cases Of Sporadic And Syndromic Vestibular Schwannoma: Fifty Shades Of Grey!
   Manjul Tripathi et al, 2019, Interdisciplinary Neurosurgery CrossRef
2. A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
   Ryota Tamura et al, 2019, Nat Commun CrossRef
3. Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma
   Masazumi Fujii et al, 2021, Current Oncology CrossRef
4. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
   Ryota Tamura, 2021, IJMS CrossRef
5. The heterogeneous subclones might be induced by cycling hypoxia which was aggravated along with the luminal A tumor growth
   Yue Kang et al, 2022, Tissue and Cell CrossRef
6. null
   Dunia Abdul-Aziz et al, 2022 CrossRef
7. null
   Venelin Gerganov et al, 2023 CrossRef
8. Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective
   Yuki Shinya et al, 2023, J Neurooncol CrossRef